HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philip Lazarovici Selected Research

ErbB Receptors (EGF Receptor)

6/2018Reverting the molecular fingerprint of tumor dormancy as a therapeutic strategy for glioblastoma.
7/2013Near infrared optical visualization of epidermal growth factor receptors levels in COLO205 colorectal cell line, orthotopic tumor in mice and human biopsies.
1/2012Bio-imaging of colorectal cancer models using near infrared labeled epidermal growth factor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philip Lazarovici Research Topics

Disease

28Neoplasms (Cancer)
12/2020 - 08/2002
12Ischemia
12/2020 - 01/2002
12Pheochromocytoma
02/2018 - 01/2002
7Glioma (Gliomas)
06/2015 - 12/2008
6Stroke (Strokes)
12/2020 - 08/2005
6Carcinoma (Carcinomatosis)
07/2013 - 01/2003
4Lung Diseases (Lung Disease)
01/2024 - 09/2015
4Pain (Aches)
12/2022 - 07/2015
4Nervous System Diseases (Neurological Disorders)
01/2022 - 01/2017
4Traumatic Brain Injuries (Traumatic Brain Injury)
01/2022 - 06/2011
4Wounds and Injuries (Trauma)
01/2018 - 06/2010
4Melanoma (Melanoma, Malignant)
10/2012 - 09/2004
3Ischemic Stroke
01/2022 - 08/2005
3Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 04/2007
3Brain Ischemia (Cerebral Ischemia)
01/2019 - 11/2012
3Reperfusion Injury
01/2019 - 01/2013
3Schizophrenia (Dementia Praecox)
01/2018 - 08/2017
3Parkinson Disease (Parkinson's Disease)
06/2007 - 01/2004
2B-Cell Lymphoma (Lymphoma, B Cell)
04/2024 - 10/2019
2Inflammation (Inflammations)
01/2024 - 09/2015
2Hyperalgesia
12/2022 - 07/2015
2COVID-19
12/2022 - 01/2022
2Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2022
2Myocardial Infarction
12/2020 - 01/2013
2Malaria
10/2019 - 01/2016
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2019 - 11/2012
2Glioblastoma (Glioblastoma Multiforme)
06/2018 - 12/2008
2Arthritis (Polyarthritis)
09/2015 - 01/2006
2Pathologic Neovascularization
09/2013 - 07/2012
2Colorectal Neoplasms (Colorectal Cancer)
07/2013 - 01/2012
2Neoplasm Metastasis (Metastasis)
03/2013 - 08/2009
2Infarction (Infarctions)
01/2013 - 06/2011
2Breast Neoplasms (Breast Cancer)
10/2012 - 01/2004
2Hypoxia (Hypoxemia)
12/2011 - 01/2011
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2006 - 01/2004
1Macular Degeneration (Age-Related Maculopathy)
04/2024
1Peripheral Nervous System Diseases (PNS Diseases)
12/2022
1Neuralgia (Stump Neuralgia)
12/2022
1Cytokine Release Syndrome
01/2022
1Virus Diseases (Viral Diseases)
01/2022
1Epilepsy (Aura)
01/2022
1Multiple Sclerosis
12/2021

Drug/Important Bio-Agent (IBA)

25Nerve Growth Factor (NGF)IBA
05/2019 - 01/2002
12Neuroprotective AgentsIBA
01/2022 - 05/2002
11Proteins (Proteins, Gene)FDA Link
04/2024 - 06/2003
9IntegrinsIBA
12/2021 - 12/2008
7Oxygen (Dioxygen)IBA
12/2020 - 01/2002
6Nerve Growth Factors (Neurotrophins)IBA
01/2021 - 10/2003
6Glucose (Dextrose)FDA LinkGeneric
12/2020 - 01/2002
6CollagenIBA
05/2013 - 03/2009
6Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA
06/2010 - 06/2003
5Dopamine (Intropin)FDA LinkGeneric
01/2018 - 10/2003
5Phosphotransferases (Kinase)IBA
01/2013 - 01/2003
4Peptides (Polypeptides)IBA
12/2020 - 09/2010
4DisintegrinsIBA
09/2020 - 12/2008
4Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA
01/2018 - 01/2004
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2015 - 08/2005
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2015 - 06/2003
4trkA ReceptorIBA
01/2007 - 06/2003
4JNK Mitogen-Activated Protein KinasesIBA
01/2007 - 01/2003
4Mitogen-Activated Protein KinasesIBA
01/2007 - 01/2003
3artemisinin (artemisinine)IBA
04/2024 - 01/2016
3Snake Venoms (Snake Venom)IBA
01/2020 - 10/2003
3tuftelin (enamelin)IBA
05/2019 - 01/2011
3ErbB Receptors (EGF Receptor)IBA
06/2018 - 01/2012
3Messenger RNA (mRNA)IBA
09/2017 - 06/2003
3Monoamine Oxidase (MAO)IBA
06/2007 - 01/2002
3Glycerol (Glycerine)FDA LinkGeneric
01/2007 - 01/2003
2Glutamic Acid (Glutamate)FDA Link
01/2022 - 08/2017
2CytokinesIBA
01/2022 - 02/2015
2Cyclic PeptidesIBA
12/2021 - 09/2020
2Monoclonal AntibodiesIBA
12/2021 - 01/2012
2Collagen ReceptorsIBA
09/2020 - 08/2009
2VenomsIBA
01/2020 - 03/2017
2CalciumIBA
02/2018 - 06/2002
2Antipsychotic Agents (Antipsychotics)IBA
01/2018 - 08/2017
2staurosporine aglycone (K252a)IBA
01/2018 - 06/2010
2Neurotransmitter Agents (Neurotransmitter)IBA
01/2018 - 08/2017
2tempolIBA
10/2016 - 11/2006
2AntibodiesIBA
08/2014 - 09/2013
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
09/2013 - 09/2006
2Epidermal Growth Factor (EGF)IBA
07/2013 - 01/2012
2rasagiline (Azilect)FDA Link
06/2007 - 01/2002
2homocarnosineIBA
02/2004 - 05/2002
1Retinal Pigments (Pigments, Visual)IBA
04/2024
1Lysine (L-Lysine)FDA Link
04/2024
1Histones (Histone)IBA
04/2024
1Retinaldehyde (Retinal)IBA
04/2024
1AMP-Activated Protein KinasesIBA
01/2024
1EnzymesIBA
01/2024
1Adenosine (Adenocard)FDA LinkGeneric
01/2024
1Gabapentin (Neurontin)FDA LinkGeneric
12/2022
1Paclitaxel (Taxol)FDA LinkGeneric
12/2022
1Antiviral Agents (Antivirals)IBA
12/2022
1Immunomodulating AgentsIBA
12/2022
1Insulin-Like Growth Factor I (IGF-1)IBA
01/2022

Therapy/Procedure

25Therapeutics
01/2024 - 08/2005
5Transplantation
02/2018 - 06/2011
3Cell- and Tissue-Based Therapy (Cell Therapy)
02/2018 - 03/2009
2Drug Therapy (Chemotherapy)
09/2017 - 10/2003